Genetic Variants Associated With Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema

Pharmacogenetics and Genomics - United States
doi 10.1097/fpc.0b013e328363c137
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Factors Associated With Hospitalization of Patients With Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema

Allergy and Asthma Proceedings
MedicineImmunologyPulmonaryAllergyRespiratory Medicine
2013English

Airway Management in Angiotensin Converting Enzyme Inhibitor Related Angioedema

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2007English

Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema – A Dangerous New Epidemic

Acta Dermato-Venereologica
DermatologyMedicine
2014English

Icatibant in the Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema

Case Reports in Critical Care
2014English

About a Case of Neurotic Angioedema Induced by Angiotensin Converting Enzyme Inhibitor

Case Reports in Clinical Medicine
2017English

Angiotensin Converting Enzyme (ACE) Inhibitor

Journal of Nihon University Medical Association
2014English

Angioedema, Angiotensin Converting Enzyme Inhibitors, and Angiotensin Receptor Blocking Drugs

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2007English

Genetic Variation in Angiotensin-Converting Enzyme–related Pathways Associated With Sudden Cardiac Arrest Risk

Heart Rhythm
Cardiovascular MedicinePhysiologyCardiology
2009English

Angiotensin-Converting Enzyme Inhibitors and Angioedema: Estimating the Risk

Hypertension
Internal Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy